Genetic variation of the 5HT transporter is associated with improvements in negative symptoms following treatment for a first episode of psychosis.

Suzanne Barrett, Richard Armstrong, Richard Anderson, Roz McCaul, Teresa Rushe, Aidan Turkington, Ciaran Mulholland, Stephen Cooper, Gavin Reynolds

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Article numberA19
Pages (from-to)A19-A19
Number of pages1
JournalJournal of Psychopharmacology
Volume22
Issue number5 (supplement)
Publication statusPublished - Jul 2008
EventBritish Association of Psychopharmacology Summer Meeting - Harrogate, UK, United Kingdom
Duration: 01 Jul 200801 Jul 2008

Bibliographical note

Medium of Output: Journal of Psychopharmacology

Cite this

Barrett, S., Armstrong, R., Anderson, R., McCaul, R., Rushe, T., Turkington, A., Mulholland, C., Cooper, S., & Reynolds, G. (2008). Genetic variation of the 5HT transporter is associated with improvements in negative symptoms following treatment for a first episode of psychosis. Journal of Psychopharmacology, 22(5 (supplement)), A19-A19. [A19].